FindTrial
Sign In

A clinical study for dipyridamole in Non-IBD colitis children

A clinical study for dipyridamole in Non-IBD colitis children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019803
Enrollment
Unknown
Registered
2018-11-30
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-IBD colitis in children

Interventions

Experimental group:dipyridamole + Heptaxidine for eight weeks
Control group:Heptaxidine for eight weeks

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0.5 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Aged 0.5-18 years old; 2. Clinical manifestations and colonoscopy confirmed non-IBD colitis; 3. Stability of vital signs; 4. Signing of informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergy to dipyridamole; 2. With bleeding tendency; 3. Patients with congenital, genetic or metabolic diseases, autoimmune diseases or immunodeficiency diseases, active tuberculosis, inflammatory bowel disease, chronic lung disease and malignancy.

Design outcomes

Primary

MeasureTime frame
CD39;Blood Platelet count;Clinical symptom score;—

Countries

China

Contacts

Public ContactYANG MIN

Guangzhou Women and Children's Medical Center

ymlyxw@foxmail.com+86 13560101008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026